Showing results (11-20 of 109) with videos related to
Sort By:
Pageof 11
Japanese Journal of Clinical Oncology|May 21, 2008
Clinical efficacy and safety of octreotide (SMS201-995) in terminally ill Japanese cancer patients with malignant bowel obstructionYasuo Shima, Atshushi Ohtsu, Kuniaki Shirao, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 22, 2012
[Efficacy assessments for chemotherapy and timing of changing treatment in gastric cancer]Yu Sunakawa, Takehiro Takahashi, Yasutsuna Sasaki, et al.Internal Medicine (Tokyo, Japan)|April 17, 2024
Tumor Lysis Syndrome in a Patient with BRAFV600E Mutated Colon Cancer Treated with Cetuximab and EncorafenibShunsuke Kasai, Etsuko Sato, Chikara Sakaguchi, et al.Current Opinion in Molecular Therapeutics|July 5, 2007
UGT1AI*6 and UGT1A1*27 for individualized irinotecan chemotherapyYuichi Ando, Ken-Ichi Fujita, Yasutsuna Sasaki, et al.Current Drug Metabolism|January 7, 2017
Toxicities of Receptor Tyrosine Kinase Inhibitors in Cancer Pharmacotherapy: Management with Clinical PharmacologyKen-Ichi Fujita, Hiroo Ishida, Yutaro Kubota, et al.World Journal of Gastroenterology|November 26, 2015
Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancerKen-ichi Fujita, Yutaro Kubota, Hiroo Ishida, et al.International Journal of Clinical Oncology|November 19, 2004
Acute gefitinib-induced pneumonitisFumiyoshi Ohyanagi, Yuichi Ando, Fumio Nagashima, et al.Breast Cancer (Tokyo, Japan)|August 25, 2011
Possible available treatment option for early stage, small, node-negative, and HER2-overexpressing breast cancerKazuhiro Araki, Shigehira Saji, Michelle Gallas, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
Orotate phosphoribosyltransferase gene polymorphism predicts toxicity in patients treated with bolus 5-fluorouracil regimenWataru Ichikawa, Takehiro Takahashi, Kenichi Suto, et al.Cancer Chemotherapy and Pharmacology|September 4, 2010
The small-molecule tyrosine kinase inhibitor nilotinib is a potent noncompetitive inhibitor of the SN-38 glucuronidation by human UGT1A1Ken-ichi Fujita, Minako Sugiyama, Yuko Akiyama, et al.Pageof 11